NCT05781529View on ClinicalTrials.gov

Injectable Platelets Rich Fibrin Versus Hyaluronic Acid for Alveolar Ridge Preservation

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

July 16, 2021

Study Completion Date

August 31, 2021

Conditions
Alveolar Ridge Enlargement
Interventions
PROCEDURE

Alveolar ridge augmentation with injectable platelets rich fibrin

Injectable platelets rich fibrin is added to xenograft for alveolar ridge augmentation in order to preserve bone and decrease bone resorption

PROCEDURE

Alveolar ridge augmentation with hyaluronic acid

Hyaluronic is added to xenograft for alveolar ridge augmentation in order to preserve bone and decrease bone resorption

PROCEDURE

Alveolar ridge augmentation with xenograft

Xenograft is added alone as a active compatator

Trial Locations (2)

11566

Doaa Adel Salah Khattab, Cairo

Doaa Khattab, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05781529 - Injectable Platelets Rich Fibrin Versus Hyaluronic Acid for Alveolar Ridge Preservation | Biotech Hunter | Biotech Hunter